HOUSE OF REPRESENTATIVES |
H.B. NO. |
1893 |
TWENTY-NINTH LEGISLATURE, 2018 |
H.D. 1 |
|
STATE OF HAWAII |
|
|
|
|
|
|
||
|
A BILL FOR AN ACT
RELATING TO HEALTH.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Chapter 329, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:
"§329- Food and Drug Administration-approved
drugs; cannabidiol. (a) Upon approval by the federal Food and Drug
Administration of one or more prescription drugs containing cannabidiol, the
following activities shall be lawful in the State:
(1) The
clinically appropriate prescription for a patient of a Food and Drug
Administration-approved prescription drug containing cannabidiol by a health
care provider licensed to prescribe medications in this State and acting within
the health care provider's authorized scope of practice;
(2) The
dispensing, pursuant to a valid prescription, of a Food and Drug
Administration-approved prescription drug containing cannabidiol to a patient
or a patient's authorized representative by a pharmacist or another health care
provider licensed to dispense medications in this State and acting within the
health care provider's authorized scope of practice;
(3) The
possession and transportation of a Food and Drug Administration-approved
prescription drug containing cannabidiol by a patient to whom a valid
prescription was issued or by the patient's authorized representative;
(4) The
possession and transportation of a Food and Drug Administration-approved
prescription drug containing cannabidiol by a licensed pharmacy or wholesaler
to facilitate the appropriate dispensing and use of the drug; and
(5) The
use of a Food and Drug Administration-approved prescription drug containing
cannabidiol by a patient to whom a valid prescription was issued; provided that
the patient uses the drug only for legitimate medical purposes in conformity
with instructions from the prescriber and dispenser.
(b) Upon approval by the Food and Drug
Administration of one or more prescription drugs containing cannabidiol, the
department shall amend its rules to conform to the requirements of subsection
(a).
(c) Nothing in this section shall be construed to amend, alter, or otherwise restrict access to medical cannabis as authorized under state law."
SECTION 2. New statutory material is underscored.
SECTION 3. This Act shall take effect on July 1, 3000.
Report Title:
Cannabis; Cannabidiol Products; Public Safety; Federal Food and Drug Administration
Description:
Allows for the medical use of cannabidiol products upon approval by the Federal Food and Drug Administration. (HB1893 HD1)
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.